Table 3.

Vessels/cardiac disorders following COVID-19 vaccines in Iran Blood involvement

Case no	Type of disorder	Age	Gender	Comorbidity	COVID-19 test/history	Vaccine type	Time of incidence	Ref.
1	Thrombotic thrombocytopenia	70	Female	Diabetes mellitus type 2, hypertension, and coronary artery disease	Not stated	ChAdOx1-S	1 day after the 1st dose	[20]
2	Vasculitis	55	Female	controlled sarcoidosis	Not stated	BBIBP–CorV	3 days after the 1st dose	[43]
3	Cerebral venous sinus thrombosis	55	Female	Hypertension/a surgery history of hysterectomy 10 years ago	Negative	ChAdOx1-S	After the 1st dose	[44]
4	Acquired thrombotic thrombocytopenic purpura (aTTP)	22	Female	–	Negative	ChAdOx1-S	3 weeks after the 1st dose	[45]
5	Purpuric dermatosis &lymphocytic vasculopathy	53	Female	History of treated breast cancer	Not stated	BBIBP–CorV	9 days after the 1st dose	[46]
6		50	Male	–	Not stated	BBIBP–CorV	2 months after vaccination	[46]
7	Myocarditis	29	Male	–	Negative	Sputnik V	2 days after the 2nd dose	[47]
8		26	Male	–	Negative	ChAdOx1-S	4 days after the 2nd dose	[48]
9		32	Female	–	Negative	ChAdOx1-S	3 days after the 1st dose	[49]
10	Atrioventricular block	65	Male	–	Not stated	BBIBP–CorV	A few days after vaccination	[50]
11	Long QT interval and syncope	70	Male	Hypertension (HTN) and diabetes mellitus under medical treatment	Negative	ChAdOx1-S	3 days after the 1st	[51]